Lysiane Molina

1.6k total citations
29 papers, 780 citations indexed

About

Lysiane Molina is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Lysiane Molina has authored 29 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Lysiane Molina's work include Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Lysiane Molina is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Lysiane Molina collaborates with scholars based in France, Canada and United States. Lysiane Molina's co-authors include Gérald Marit, Marie‐Cécile Michallet, Nicole Dastugue, Josy Reiffers, Mårina Lafage‐Pochitaloff, Pierre–Henri Bernard, A. M. Stoppa, Catherine Payen, D Hollard and D Maraninchi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lysiane Molina

29 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lysiane Molina France 14 544 237 159 154 120 29 780
Paola Carluccio Italy 15 412 0.8× 176 0.7× 138 0.9× 159 1.0× 107 0.9× 45 612
Gönül Hiçsönmez Türkiye 18 581 1.1× 269 1.1× 92 0.6× 265 1.7× 123 1.0× 74 910
PA Cassileth United States 6 532 1.0× 194 0.8× 287 1.8× 156 1.0× 88 0.7× 13 696
Charikleia Kelaïdi France 14 457 0.8× 53 0.2× 94 0.6× 197 1.3× 292 2.4× 45 742
DW Beelen Germany 14 750 1.4× 171 0.7× 178 1.1× 113 0.7× 142 1.2× 18 877
Hassan B. Alkhateeb United States 14 502 0.9× 125 0.5× 116 0.7× 190 1.2× 222 1.9× 148 743
Youcef Chelghoum France 12 269 0.5× 180 0.8× 151 0.9× 134 0.9× 85 0.7× 35 466
Ana Vidović Serbia 13 406 0.7× 74 0.3× 89 0.6× 192 1.2× 165 1.4× 74 585
Ken Ishiyama Japan 17 555 1.0× 115 0.5× 186 1.2× 77 0.5× 136 1.1× 100 865
Rıdvan Ali Türkiye 14 348 0.6× 129 0.5× 216 1.4× 165 1.1× 130 1.1× 55 609

Countries citing papers authored by Lysiane Molina

Since Specialization
Citations

This map shows the geographic impact of Lysiane Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lysiane Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lysiane Molina more than expected).

Fields of papers citing papers by Lysiane Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lysiane Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lysiane Molina. The network helps show where Lysiane Molina may publish in the future.

Co-authorship network of co-authors of Lysiane Molina

This figure shows the co-authorship network connecting the top 25 collaborators of Lysiane Molina. A scholar is included among the top collaborators of Lysiane Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lysiane Molina. Lysiane Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Bei, Patrick M. Reagan, Laurie H. Sehn, et al.. (2025). Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Advances. 9(10). 2489–2499. 3 indexed citations
2.
Carras, Sylvain, Barbara Burroni, Elsa Maître, et al.. (2024). Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review. SHILAP Revista de lepidopterología. 5(1). 242–246. 2 indexed citations
3.
Reagan, Patrick M., Laurie H. Sehn, Jeff P. Sharman, et al.. (2023). Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.. Journal of Clinical Oncology. 41(16_suppl). 7518–7518. 2 indexed citations
4.
Aurran‐Schleinitz, Thérèse, Cécile Tomowiak, Damien Roos‐Weil, et al.. (2022). Combined Treatment with Ibrutinib and Anti-CD38 Monoclonal Antibody Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia with TP53 Aberrations: Results of the Filo Phase II Study IDA53. Blood. 140(Supplement 1). 7030–7031. 3 indexed citations
5.
6.
Guièze, Romain, Loïc Ysebaert, Lysiane Molina, et al.. (2020). Blinatumomab after R-CHOP Debulking Therapy for Patients with Richter Transformation: Preliminary Results of the Multicenter Phase 2 Blinart Trial from the Filo Group. Blood. 136(Supplement 1). 4–5. 2 indexed citations
7.
Carras, Sylvain, Delphine Sénécal, Jean-Philippe Jaı̈s, et al.. (2018). Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial. Clinical Lymphoma Myeloma & Leukemia. 18(3). 191–198. 7 indexed citations
8.
Oliveras, Anna, Pedro Armario, Laia Sans, et al.. (2016). [OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS. Journal of Hypertension. 34(Supplement 2). e47–e47. 1 indexed citations
9.
Maubon, Danièle, Jean‐Pierre Brion, Patrice François, et al.. (2013). Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. European Journal of Clinical Microbiology & Infectious Diseases. 33(3). 331–336. 60 indexed citations
10.
Brenier‐Pinchart, Marie‐Pierre, B. Lebeau, Jean-Louis Quésada, et al.. (2011). Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: a relationship?. Clinical Microbiology and Infection. 17(9). 1387–1390. 11 indexed citations
11.
Brenier‐Pinchart, Marie‐Pierre, B. Lebeau, Jean-Louis Quésada, et al.. (2009). Influence of internal and outdoor factors on filamentous fungal flora in hematology wards. American Journal of Infection Control. 37(8). 631–637. 29 indexed citations
12.
Jourdan, Éric, Françoise Rigal‐Huguet, Gérald Marit, et al.. (2005). Oneversustwo high‐dose cytarabine‐based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission. British Journal of Haematology. 129(3). 403–410. 11 indexed citations
13.
Jourdan, Éric, Jean‐Michel Boiron, Nicole Dastugue, et al.. (2005). Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat Long-Term Analysis of the BGMT Experience. Journal of Clinical Oncology. 23(30). 7676–7684. 39 indexed citations
14.
Boulat, Olivier, Françoise Rigal‐Huguet, Lysiane Molina, et al.. (2001). A Randomized Prospective Multicentre Trial of Cefpirome Versus Piperacillin-Tazobactam in Febrile Neutropenia. Leukemia & lymphoma. 42(3). 379–386. 14 indexed citations
15.
Michallet, Mauricette, Amine Belhabri, Lysiane Molina, et al.. (1999). Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 23(2). 145–150. 16 indexed citations
16.
Socié, Gèrard, J Cahn, Vernant Jp, et al.. (1997). Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). British Journal of Haematology. 97(4). 865–870. 96 indexed citations
17.
18.
Dastugue, Nicole, Catherine Payen, Mårina Lafage‐Pochitaloff, et al.. (1995). Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group.. PubMed. 9(9). 1491–8. 199 indexed citations
19.
Michallet, Mauricette, Bernadette Corront, Lysiane Molina, et al.. (1991). Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients.. PubMed. 8(1). 13–7. 23 indexed citations
20.
Michallet, Mauricette, Bernadette Corront, Lysiane Molina, et al.. (1991). Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT. Leukemia & lymphoma. 5(sup1). 127–131. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Carluccio Breakdown of academic impact, for papers by Gönül Hiçsönmez Breakdown of academic impact, for papers by PA Cassileth Breakdown of academic impact, for papers by Charikleia Kelaïdi Breakdown of academic impact, for papers by DW Beelen Breakdown of academic impact, for papers by Hassan B. Alkhateeb Breakdown of academic impact, for papers by Youcef Chelghoum Breakdown of academic impact, for papers by Ana Vidović Breakdown of academic impact, for papers by Ken Ishiyama Breakdown of academic impact, for papers by Rıdvan Ali
Rankless by CCL
2026